Search Results

2301 - 2325 of 100656
TitleWireDateTime
Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates Globe Newswire 04/20 08:00
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® Globe Newswire 04/20 08:00
Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth Globe Newswire 04/20 08:00
Cole West Closes on 38 Homesites in Northern Utah for New Community Globe Newswire 04/20 08:00
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis Globe Newswire 04/20 08:00
Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent Interview Globe Newswire 04/20 08:00
Precedence Research Launches Advanced Cell and Gene Therapy Intelligence Platform to Transform Complex CGT Data into Strategic Decisions Globe Newswire 04/20 07:58
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue Globe Newswire 04/20 07:50
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source Globe Newswire 04/20 07:42
Thermal Imaging Market to Cross $8.78 Billion by 2034 at CAGR of 7.2%: New Research by The Insight Partners Globe Newswire 04/20 07:39
SLEEK Debuts Universal Profiles at Sophie Passmann Book Club, Pioneering a New Template for Cultural Fan Activation Globe Newswire 04/20 07:34
Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System Globe Newswire 04/20 07:32
Dragonfly Energy Secures Multi-Million Dollar Order from Stevens Transport, Marking a Major Commercial Milestone Globe Newswire 04/20 07:30
Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026 Globe Newswire 04/20 07:30
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region Globe Newswire 04/20 07:30
AlphaTON Capital Rebrands as Alpha Compute Corp. to Reflect Its Growing AI Compute Business Globe Newswire 04/20 07:30
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors Globe Newswire 04/20 07:30
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026 Globe Newswire 04/20 07:30
Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122% Globe Newswire 04/20 07:30
Claire’s Place Foundation’s Glow Ride Returns to Hermosa Beach for CF Awareness Month Globe Newswire 04/20 07:18
New Found Gold Announces $205M Finance Package Globe Newswire 04/20 07:15
Toobit Announces $150,000 Event Contracts Campaign with Daily Win Rewards Globe Newswire 04/20 07:12
Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons Globe Newswire 04/20 07:05
Gilat to Report First Quarter 2026 Results on Wednesday, May 13th Globe Newswire 04/20 07:02
Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Globe Newswire 04/20 07:01
2301 - 2325 of 100656

News, Photo and Web Search

Search News by Ticker